Claim/exemption information - Registry number 3504914

Disclose a statement to the effect that actual concentrations are withheld as a trade secret, where prescribed concentration ranges are used.

Disclose all headings as set out in column 1 of Schedule 1, specifically “Identification” and “Other information”.

Disclose an adequate product odour.

Disclose either the name of the symbol or the symbol itself for each of the applicable product hazard classifications, specifically “skull and crossbones” and “health hazard”.

Disclose the HMIRA registry number and correct date of decision, and clearly link which ingredients and concentrations are part of the subject of the claim for exemption under the HMIRA. Please note all references to the HMIRA on the product SDS, with respect to the subjects of the claim that are invalid, must be removed.

Disclose the additional hazard classifications for the product (see appendix 1).

Disclose the common name and synonyms for the ingredients listed in section 3 of the SDS.

Disclose the correct and complete LD50 and LC50 values (see appendix 5).

Disclose the hazard statements for each of the product hazard classification categories or subcategories (see appendix 2).

Disclose the hazardous ingredient “exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate”, “4,4'-isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, esters with acrylic acid”, "1-Hydroxy-4-(p-toluidino)anthraquinone-C.I. Solvent Violet 13" and “Ethoxylated Trimethylolpropane Triacrylate”.

Disclose the information on personal protective equipment in section 6 of the SDS.

Disclose the other hazards known to the supplier with respect to the hazardous product.

Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 2).

Disclose the product oral and inhalation (dust/mist) acute toxicity estimates (ATEs) of 5,300 mg/kg (0% unknown) and 0.85 mg/L (83% unknown), respectively (see appendix 5).

Disclose the relevant conditions for safe storage (see appendix 4).

Disclose the relevant first-aid measures for inhalation and skin contact (see appendix 3).

Remove all forward slashes or diagonal marks in precautionary statements for which a choice is to be made.

Remove all forward slashes or diagonal marks in the hazard classifications for which a choice is to be made.